Johnson Matthey PLC (LON:JMAT - Get Free Report)'s stock price rose 32.5% during trading on Thursday . The company traded as high as GBX 1,888 ($25.32) and last traded at GBX 1,841 ($24.69). Approximately 4,587,394 shares changed hands during trading, an increase of 66% from the average daily volume of 2,755,721 shares. The stock had previously closed at GBX 1,389 ($18.63).
Johnson Matthey Trading Up 32.5%
The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45. The business's fifty day moving average is GBX 1,294.86 and its 200-day moving average is GBX 1,372.17. The firm has a market cap of £3.08 billion, a P/E ratio of 31.28, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95.
Johnson Matthey (LON:JMAT - Get Free Report) last issued its quarterly earnings data on Thursday, May 22nd. The company reported GBX 149.20 ($2.00) EPS for the quarter. Johnson Matthey had a return on equity of 4.49% and a net margin of 0.84%. Analysts predict that Johnson Matthey PLC will post 173.4112903 EPS for the current year.
Johnson Matthey Increases Dividend
The company also recently declared a dividend, which was paid on Wednesday, April 16th. Stockholders of record on Thursday, April 10th were given a dividend of GBX 32 ($0.43) per share. This is a positive change from Johnson Matthey's previous dividend of $22.00. This represents a dividend yield of 1.88%. The ex-dividend date was Thursday, April 10th. Johnson Matthey's payout ratio is 130.84%.
Insider Activity at Johnson Matthey
In related news, insider Liam Condon bought 27 shares of the company's stock in a transaction on Wednesday, March 19th. The shares were acquired at an average cost of GBX 1,445 ($19.38) per share, with a total value of £390.15 ($523.20). 0.61% of the stock is owned by insiders.
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
